Crestor study has ‘profound implications’ for NICE guidance
November 14, 2008Sales and Marketing Crestor, cv, lipid
AstraZeneca's statin Crestor made national headlines this week when it was shown to dramatically reduce major cardiovascular events. New data …
GSK delays US filing of Solzira
November 14, 2008Sales and Marketing GSK, restless legs
GlaxoSmithKline has withdrawn the US application for its restless legs syndrome treatment Solzira. The company, along with co-developer XenoPort, is …
UK set for new flexible drug pricing, says Johnson
November 14, 2008Sales and Marketing NHS, par
The government is working with the pharma industry on new 'flexible pricing' arrangements, even though revisions to the existing PPRS …
Good Publication Practice 2: updating best practice
November 13, 2008Research and Development, Sales and Marketing GPP, Good Publication Practice, clinical trials, ethics, journals, publication
Results from clinical trials are the very lifeblood of the pharmaceutical industry, representing the frontline in the search for new …
MedImmune broadens drug discovery in Cambridge
November 13, 2008Research and Development Cambridge, MedImmune
MedImmune, AstraZeneca's biotech arm, has opened a new R&D facility in Cambridge as part of a major expansion of its …
200m from prescribing budgets to pay pharmacists
November 13, 2008NHS, primary
PCTs will have to make major and unplanned cuts to their drugs budgets and divert the money to shore up …
Information ‘seal of approval’ by summer 2009
November 13, 2008Medical Communications patients
The UK wants to improve access to information on health and social care by launching a new 'seal of approval' …
Government delays PPRS to maximise savings
November 12, 2008Sales and Marketing ABPI, par
The PPRS deal agreed in principle this summer has been now thrown into confusion by government, with its launch at …
UK is example to Europe on patient information, says industry
November 12, 2008Medical Communications ABPI, patients
British pharma is free to provide necessary and sufficient information to patients about its drugs, and is an example to …
Amgen talks up blockbuster prospects
November 12, 2008Research and Development, Sales and Marketing Amgen
Amgen says two of its pipeline products are potential blockbusters in three indications. The company is keen to reaffirm its …
US survey highlights co-payment worries
November 11, 2008Sales and Marketing US, hc, reform
A US survey has shown that concern about the high cost of medicines means that many patients are not taking …
Patheon opens European headquarters in Switzerland
November 11, 2008Research and Development Patheon
Contract research organisation Patheon has opened a new European head office in Zug, Switzerland, near Zurich. The new headquarters will …
Pharma and NICE must end games of ‘one-upmanship’
November 10, 2008Sales and Marketing NHS, par
Patient groups are calling on a pharmaceutical company to reach a compromise with NICE over a bone marrow cancer drug. …
Working Life: Viggo Birch
November 10, 2008Business Services, Research and Development, Sales and Marketing Novo Nordisk, WL, careers
How did you arrive at your current position?A long story. I started in Mobil Oil in Denmark after graduating from …
Latest news from Datamonitor
November 10, 2008Research and Development, Sales and Marketing HRT
Is there an alternative to HRT for menopausal relief?Sales of hormone replacement therapy have declined recently due to safety concerns, …
Emerging markets shine for AstraZeneca
November 6, 2008Sales and Marketing AZ, China, hc
AstraZeneca saw overall sales for the three months to September rise 3% to $7.8 billion. But growth in emerging markets …
Major economies facing recession
November 6, 2008Sales and Marketing hc
The UK, US and Japan must brace themselves for a full year of recession in 2009, according to economists. The …
Healthcare challenges ahead for Obama
November 6, 2008Sales and Marketing US, reform
After his resounding election victory, America's new President-Elect Barack Obama is already assembling his White House team. During the election, …
NICE to collect its own patient data
November 6, 2008Sales and Marketing NICE
NICE's chairman Prof Sir Michael Rawlins has revealed some details of how it will change to ensure more patients will …
Medicine top-ups to be allowed
November 5, 2008Sales and Marketing NICE, par
The ban on NHS patients using top-up payments to receive privately-prescribed medicines has been lifted in a move aimed at …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
